# ADAPALENE AND BENZOYL PEROXIDE
> **ANDA209641** · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS LABS UT INC · Approved 2022-06-22
## Drug
- **FDA Application Number:** ANDA209641
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ADAPALENE AND BENZOYL PEROXIDE
- **Generic name:** ADAPALENE AND BENZOYL PEROXIDE
- **Active ingredients:** ADAPALENE; BENZOYL PEROXIDE
- **Dosage form:** GEL
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** ACTAVIS LABS UT INC
- **Manufacturer:** Teva Pharmaceuticals, Inc.
- **First approval:** 2022-06-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209641)
---
*AI Analytics · CC0 1.0*